Drop in Pay-for-Delay Good for Access to Medicines in Europe

Press Statement | 8 July 2011 | PDF

This week the European Commission revealed a fall in problematic medicines patent settlements. This is good news for public health because intentional delays in opening the medicines market to competition can prevent patients from accessing the medicines they need.

Read more…

START TYPING AND PRESS ENTER TO SEARCH